Nadee Nissanka
Nadee Nissanka
Postdoctoral Associate, University of Miami
Verified email at med.miami.edu
Title
Cited by
Cited by
Year
Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
N Nissanka, CT Moraes
FEBS letters 592 (5), 728-742, 2018
1322018
MitoTALEN reduces mutant mtDNA load and restores tRNA Ala levels in a mouse model of heteroplasmic mtDNA mutation
SR Bacman, JHK Kauppila, CV Pereira, N Nissanka, M Miranda, M Pinto, ...
Nature medicine 24 (11), 1696-1700, 2018
952018
Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness
Z Zakirova, M Tweed, G Crynen, J Reed, L Abdullah, N Nissanka, ...
PloS one 10 (3), e0119579, 2015
512015
The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions
N Nissanka, SR Bacman, MJ Plastini, CT Moraes
Nature communications 9 (1), 1-9, 2018
442018
Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
M Pinto, N Nissanka, S Peralta, R Brambilla, F Diaz, CT Moraes
Molecular neurodegeneration 11 (1), 1-15, 2016
422016
ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels
S Peralta, S Goffart, SL Williams, F Diaz, S Garcia, N Nissanka, ...
Journal of cell science 131 (13), 2018
332018
Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson's disease
M Pinto, N Nissanka, CT Moraes
Journal of Neuroscience 38 (4), 1042-1053, 2018
332018
Mechanisms of mitochondrial DNA deletion formation
N Nissanka, M Minczuk, CT Moraes
Trends in Genetics 35 (3), 235-244, 2019
302019
Overexpression of PGC‐1α in aging muscle enhances a subset of young‐like molecular patterns
S Garcia, N Nissanka, EA Mareco, S Rossi, S Peralta, F Diaz, RL Rotundo, ...
Aging cell 17 (2), e12707, 2018
252018
Photobiomodulation enhancement of cell proliferation at 660 nm does not require cytochrome c oxidase
PLV Lima, CV Pereira, N Nissanka, T Arguello, G Gavini, ...
Journal of Photochemistry and Photobiology B: Biology 194, 71-75, 2019
202019
Mitochondrial DNA heteroplasmy in disease and targeted nuclease‐based therapeutic approaches
N Nissanka, CT Moraes
EMBO reports 21 (3), e49612, 2020
142020
Magnetic systems for tarsorrhaphy
A Barmettler, N Nissanka, MI Rosenblatt, R Rao, D Lipson, GJ Lelli Jr
Ophthalmic Plastic & Reconstructive Surgery 30 (4), 305-308, 2014
102014
Author Correction: MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation.
SR Bacman, JHK Kauppila, CV Pereira, N Nissanka, M Miranda, M Pinto, ...
Nature medicine 24 (12), 1940-1940, 2018
32018
Cybrid technology
SR Bacman, N Nissanka, CT Moraes
Methods in Cell Biology 155, 415-439, 2020
22020
Decellularized human bone as a 3D model to study skeletal progenitor cells in a natural environment
AR Pereira, M Rudert, M Herrmann
Methods in cell biology 157, 123-141, 2020
12020
Image-Based Analysis of Mitochondrial Area and Counting from Adult Mouse Dopaminergic Neurites
N Nissanka, CT Moraes, M Pinto
Bio-protocol 8 (16), e2471-e2471, 2018
12018
Magnetic control of eyelid position
D Lipson, GJ Lelli, M Rosenblatt, R Rao, N Nissanka
US Patent 9,020,600, 2015
12015
Hypoxia Promotes Mitochondrial Complex I Abundance via HIF-1α in Complex III and Complex IV Eficient Cells
A Saldana-Caboverde, N Nissanka, S Garcia, A Lombès, F Diaz
Cells 9 (10), 2197, 2020
2020
ELIMINATION OF MUTANT MITOCHONDRIAL GENOMES BY MITOCHONDRIAL-TARGETED DNA EDITING ENZYMES
CT Moraes, SR Bacman, N Nissanka, CV Pereira, U Zekonyte, JB Stewart
MOLECULAR GENETICS AND METABOLISM 127 (3), 231-231, 2019
2019
Gene Therapy for Mitochondrial Diseases
SR Bacman, JH Kauppila, CV Pereira, N Nissanka, M Miranda, M Pinto, ...
MOLECULAR THERAPY 27 (4), 179-179, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20